A detailed history of Black Rock Inc. transactions in Opti Nose, Inc. stock. As of the latest transaction made, Black Rock Inc. holds 5,274,114 shares of OPTN stock, worth $3.69 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
5,274,114
Previous 4,283,316 23.13%
Holding current value
$3.69 Million
Previous $6.25 Million 12.28%
% of portfolio
0.0%
Previous 0.0%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024

BUY
$0.82 - $1.44 $812,454 - $1.43 Million
990,798 Added 23.13%
5,274,114 $5.49 Million
Q1 2024

May 10, 2024

SELL
$1.17 - $1.94 $141,493 - $234,613
-120,935 Reduced 2.75%
4,283,316 $6.25 Million
Q4 2023

Feb 13, 2024

BUY
$1.02 - $1.47 $230,908 - $332,780
226,381 Added 5.42%
4,404,251 $5.68 Million
Q3 2023

Nov 13, 2023

BUY
$0.93 - $1.38 $255,392 - $378,970
274,616 Added 7.04%
4,177,870 $5.14 Million
Q2 2023

Aug 11, 2023

BUY
$1.11 - $2.05 $3.6 Million - $6.65 Million
3,246,231 Added 494.08%
3,903,254 $4.8 Million
Q1 2023

May 12, 2023

BUY
$1.63 - $2.02 $47,925 - $59,392
29,402 Added 4.68%
657,023 $1.27 Million
Q4 2022

Feb 13, 2023

SELL
$1.68 - $3.7 $54,295 - $119,580
-32,319 Reduced 4.9%
627,621 $1.16 Million
Q3 2022

Nov 14, 2022

SELL
$3.43 - $4.01 $279,016 - $326,197
-81,346 Reduced 10.97%
659,940 $2.42 Million
Q2 2022

Aug 12, 2022

SELL
$1.76 - $3.82 $54,744 - $118,821
-31,105 Reduced 4.03%
741,286 $2.71 Million
Q1 2022

May 12, 2022

BUY
$1.77 - $2.93 $39,224 - $64,931
22,161 Added 2.95%
772,391 $1.91 Million
Q4 2021

Feb 10, 2022

BUY
$1.55 - $3.1 $31,147 - $62,294
20,095 Added 2.75%
750,230 $1.22 Million
Q3 2021

Nov 09, 2021

BUY
$2.35 - $3.16 $276,877 - $372,311
117,820 Added 19.24%
730,135 $2.19 Million
Q2 2021

Aug 11, 2021

BUY
$2.91 - $3.83 $1.78 Million - $2.35 Million
612,315 New
612,315 $1.9 Million

Others Institutions Holding OPTN

About OptiNose, Inc.


  • Ticker OPTN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 83,277,504
  • Market Cap $58.3M
  • Description
  • OptiNose, Inc., a specialty pharmaceutical company, focuses on the development and commercialization of products for patients treated by ear, nose, throat, and allergy specialists in the United States. The company offers XHANCE, a therapeutic product utilizing its proprietary exhalation delivery system (EDS) that delivers a topically-acting cort...
More about OPTN
Track This Portfolio

Track Black Rock Inc. Portfolio

Follow Black Rock Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Black Rock Inc., based on Form 13F filings with the SEC.

News

Stay updated on Black Rock Inc. with notifications on news.